Association between genetic variations in surfactant protein D and emphysema, interstitial pneumonia, and lung cancer in a Japanese population

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 9, Issue 4, 2012, Pages 409-416

  Ishii, Takeo ^a   Hagiwara, Koichi ^b   Ikeda, Shinobu ^c   Arai, Tomio ^d   Mieno, Makiko Naka ^e   Kumasaka, Toshio ^f   Muramatsu, Masaaki ^c   Sawabe, Motoji ^d   Gemma, Akihiko ^a   Kida, Kozui ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d Tokyo Metropolitan Institute of Gerontology   (Japan)

^e JICHI MEDICAL UNIVERSITY   (Japan)

^f JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; METHIONINE; SURFACTANT PROTEIN D; THREONINE;

AGED; ARTICLE; AUTOPSY; EMPHYSEMA; FEMALE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTERSTITIAL PNEUMONIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; FEMALE; GENETIC MARKERS; GENOTYPING TECHNIQUES; HAPLOTYPES; HUMANS; JAPAN; LOGISTIC MODELS; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY EMPHYSEMA; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D;

EID: 84865189698     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2012.676110     Document Type: Article

References (43)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49.
2. Marugame T, Yoshimi I. Comparison of cancer mortality (lung cancer) in fi ve countries: France, Italy, Japan, UK and USA from the WHO Mortality Database (1960-2000). Jpn J Clin Oncol 2005;35:168-70.
3. Marugame T, Mizuno S. Mortality trend of lung cancer in Japan: 1960-2000. Jpn J Clin Oncol 2003;33:148-9.
4. Kiyohara C, Otsu A, Shirakawa T, et al. Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer 2002;37:241-56.
5. Th orgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008;452:638-42.
6. Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008;452:633-7.
7. Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifi es a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008;40:616-22.
8. Shiraishi K, Kohno T, Kunitoh H, et al. Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in smoking-independent manner in the Japanese. Carcinogenesis 2009;30:65-70.
9. Itzkowitz SH, Yio X. Infl ammation and cancer IV. Colorectal cancer in infl ammatory bowel disease: the role of infl ammation. Am J Physiol Gastrointest Liver Physiol 2004;287:G7-17.
10. de Torres JP, Bastarrika G, Wisnivesky JP, et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 2007;132:1932-8.
11. Wilson DO, Weissfeld JL, Balkan A, et al. Association of radiographic emphysema and airfl ow obstruction with lung cancer. Am J Respir Crit Care Med 2008;178:738-44.
12. Matsushita H, Tanaka S, Saiki Y, et al. Lung cancer associated with usual interstitial pneumonia. Pathol Int 1995;45:925-32.
13. Parimon T, Chien JW, Bryson CL, et al. Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:712-19.
14. Yoshida T, Tuder RM. Pathobiology of cigarette smokeinduced chronic obstructive pulmonary disease. Physiol Rev 2007;87:1047-82.
15. McCormack FX, Whitsett JA. Th e pulmonary collectins, SP- and SP-D, orchestrate innate immunity in the lung. J Clin Invest 2002;109:707-12.
16. Wang Y, Kuan PJ, Xing C, et al. Genetic defects in surfactant protein A2 are associated with pulmonary fi brosis and lung cancer. Am J Hum Genet 2009;84:52-9.
17. Ewis AA, Kondo K, Dang F, et al. Surfactant protein B gene variations and susceptibility to lung cancer in chromate workers. Am J Ind Med 2006;49:367-73.
18. Sin DD, Man SF, McWilliams A, et al. Surfactant protein D and bronchial dysplasia in smokers at high risk of lung cancer. Chest 2008;134:582-8.
19. Ishii T, Hagiwara K, Kamio K, et al. Involvement of surfactant protein D in emphysema revealed by genetic association study. Eur J Hum Genet 2012;20:230-5.
20. Foreman MG, Kong X, Demeo DL, et al. Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2011;44:316-22.
21. National Heart, Lung, and Blood Institute. Th e defi nition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. Am Rev RespirDis 1985;132:182-5.
22. Yamanaka A. Morphopathology of chronic pulmonary emphysema. Acta Pathol Jpn 1965;15:33-9.
23. Fujimoto K, Ikeda S, Arai T, et al. Polymorphism of SERPINE2 gene is associated with pulmonary emphysema in consecutive autopsy cases. BMC Med Genet 2010;11:159-65.
24. Wright JL, Th urlbeck WM, editors. Emphysema: classifi cation, morphology, and associations. Th urlbecks Chronic Airfl ow Obstruction. 2nd ed. Hamilton (ON): B.C. Decker, Inc.; 1999. Chapter 4; p. 85-144.
25. Myers JL. Th urlbecks pathology of the lung. 3rd ed. New York: Th ieme Medical Publishers, Inc.; 2005. Chapter 20, Idiopathic interstitial pneumonias; p. 563-600.
26. Myers JL. Other diff use lung diseases. Th urlbecks Pathology of the Lung. 3rd ed. Wright JL, Th urlbeck WM, editors. New York: Th ieme Medical Publishers, Inc., 2005; Chapter 21; pp. 601-74.
27. Holland PM, Abramson RD, Watson R, et al. Detection of specifi c polymerase chain reaction product by utilizing the 5?-3? exonuclease activity of Th ermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 1991;88:7276-80.
28. Baron RM, Kenny DA. Th e moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-82.
29. Wang J, Spitz MR, Amos CI, et al. Mediating eff ects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk. Cancer 2010;116:3458-62.
30. Kenny DA, Kashy DA, Bolger N. Data analysis in social psycho-logy. Th e Handbook of Social Psychology. Gilbert DT, Fiske ST, Lindzey G, editors. Boston: McGraw-Hill; 1998; p. 233-65.
31. MacKinnon A. Estimating mediated eff ects in prevention studies. Eval Rev 1993;17:144-58.
32. Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect eff ects in simple mediation models. Behav Res Methods Instrum Comput 2004;36:717-31.
33. Raghu G, Collard HR, Egan JJ, et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An offi cial ATS/ ERS/JRS/ALAT statement: idiopathic pulmonary fi brosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
34. Leth-Larsen R, Garred P, Jensenius H, et al. A common polymorphism in the SFTPD gene infl uences assembly, function, and concentration of surfactant protein D. J Immunol 2005;174:1532-8.
35. Sorensen GL, Hoegh SV, Leth-Larsen R, et al. Multimeric and trimeric subunit SP-D are interconvertible structures with distinct ligand interaction. Mol Immunol 2009;46:3060-9.
36. Shiels MS, Chaturvedi AK, Katki HA, et al. Circulating markers of interstitial lung disease and subsequent risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2011;20:2262-72.
37. de Gracia J, Mata F, Alvarez A, et al. Genotype-phenotype correlation for pulmonary function in cystic fi brosis. Th orax 2005;60:558-63.
38. Cohen JC, Kiss RS, Pertsemlidis A, et al. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 2004;305:869-72.
39. Matakidou A, Eisen T, Houlston RS. TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 2003;18:377-85.
40. Ligtenberg AJ, Veerman EC, Nieuw Amerongen AV, et al. Salivary agglutinin/glycoprotein-340/DMBT1: a single molecule with variable composition and with diff erent functions in infection, infl ammation and cancer. Biol Chem 2007;388:1275-89.
41. Wu W, Kemp BL, Proctor ML, et al. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. Cancer Res 1999;59:1846-51.
42. Bridges JP, Wert SE, Nogee LM, et al. Expression of a human surfactant protein C mutation associated with interstitial lung disease disrupts lung development in transgenic mice. J Biol Chem 2003;278:52739-46.
43. Mulugeta S, Nguyen V, Russo SJ, et al. A surfactant protein C precursor protein BRICHOS domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation. Am J Respir Cell Mol Biol 2005;32:521-30.